University of Mississippi researchers are developing a novel treatment for the neurological complications of HIV, also known as neuro-HIV. The National Institutes of Health awarded a five-year grant ...
LONDON, UNITED KINGDOM, September 30, 2024 /EINPresswire.com/ -- The QPAN ® (QEEG-Guided Personalised AI-Based Neuromodulation and Rehabilitation) Model is a ...
Please provide your email address to receive an email when new articles are posted on . Biotechnology startup company Camellix has announced the discovery of a green tea-derived polyphenol molecule ...
ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of ...
ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of ...
Neuro Vigor, a Purdue University-affiliated biotechnology company developing drugs that neutralize reactive aldehydes, announced Tuesday (Oct. 26) a collaboration agreement with the University of ...
July 24 (Reuters) - Biogen (BIIB.O), opens new tab and Sage Therapeutics (SAGE.O), opens new tab do not plan to conduct further studies for their neurological disorder drug after it failed in a ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...
thesun.ng on MSN
On Ataben’s contributions to neurological studies in Nigeria
By Grateful OgunjebeOn December 23, 2025, an article titled ‘Neurologist raises the alarm over rising stroke cases among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results